Senior insider sale
SVP, Chief Development Officer at MERSANA THERAPEUTICS, INC. — senior position signals high conviction
$9.3K
11.08K shares
What this filing means
BALA MOHAN plans to sell 11.08K shares of MERSANA THERAPEUTICS, INC. valued at approximately $9.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/17/2025ACC: 0001104659-25-004582
Officer· SVP, Chief Development Officer
Since Sep 2023
11.08K
Shares to sell
$9.3K
Approx. market value
14.58K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit grant
Services rendered
1/15/2025
14.58KTotal acquired14.58K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2025 | Vesting of restricted stock unit grant Services rendered | 14.58K | — |
| Total | 14.58K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.25K
Market value
$2.1K
1/14/2025
—Completed
Units to sell
1.88K
Market value
$3.6K
10/28/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.94K
Market value
$3.6K
1/16/2025
Total
Units
11.08K
Value
$9.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/14/2025 | 3.25K | $2.1K | — | Completed |
10/28/2024 | 1.88K | $3.6K | — | Completed |
| Planned — Approximate Date | ||||
1/16/2025 | 5.94K | $3.6K | NASDAQ | Planned |
| Total | 11.08K | $9.3K | ||